All News

Telemedicine.MD.Computer.phone (keep)

Paucity of Effectiveness Research on Telemedicine in RA

d Jack Cush, MD

A systematic review of telehealth in delivering equivalent care in RA patients demonstrates there is limited evidence that virtual RA care is equivalent to conventional face-to-face care. Despite current widespread use, there is a great need for credible well-designed research that will address comparable patient outcomes, implementation strategies and long‐term health system consequences. 

Read Article
Gout pills injection

Combo Therapy Boosts Response in Uncontrolled Gout

d MedPage Today

The addition of an immunomodulating agent to pegloticase (Krystexxa) among patients with uncontrolled gout significantly improved response rates, a systematic literature review found.

Read Article
IL-6 IL6 cells cytokine

NEJM: Interleukin-6 Inhibition in Critically-Ill COVID-19

d Jack Cush, MD

The pendulum and jury are wavering with regard to the benefits of interleukin-6 receptor antagonists in COVID-19; the current NEJM reports the results of a study favoring such biologic therapy in in critically ill COVID-19 patients.

Read Article
GSKs RCT showed otilimab (investigational anti-GM-CSF Ab) in severe COVID-19, was not superior to SOC for the primary endpoint - the proportion alive and free of respiratory failure at 28 days (but was effective in pts >70 yrs (65% vs 46%) https://t.co/OHvWGGlgKv

Links:

Dr. John Cush RheumNow ( View Tweet)

620 RA patients from Nordic biologics registers started a non-TNFi as 1steverr bDMARD but later switched to a 2nd bDMARD (ABA 86, RTX 40, TCZ 67 TNFi 427). Retention was 70% @ 6 mos & 50% @12 mos. 30-40% on 2nd bDMARD reached LDAS or remission https://t.co/u8BQn0rYca

Links:

Dr. John Cush RheumNow ( View Tweet)

Influenza vaccinations may hit a record high this season. Last year 48.4% of Americans got the flu shot. Survey suggests that nearly two-thirds will have flu vax this year (44% already had a flu shot, 13.5% said they will get& 9.3% said probably will get) https://t.co/3CnIdx49rW https://t.co/Khp6wsahCD

Links:

Dr. John Cush RheumNow ( View Tweet)
Report from DANBIO Danish register looked at chronic pain in a matched cohort study of Psoriasis. Chronic pain was not associated with excess mortality (hence not PsA) (OR 0.99,0.95-1.03). Mortality was increased with steriods, COPD, DM, CA, CV disease.  https://t.co/91JW3BOPtw

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: NEJM: Interleukin-6 Inhibition in Critically-Ill COVID-19 https://t.co/IrKnTlPDpK https://t.co/8topsI3nQN

Links:

Dr. John Cush RheumNow ( View Tweet)
QD Clinic - Self-Medicating Myself Getting pills from Mexico, Spouse or the Dog? https://t.co/jcAmyhihN5 https://t.co/68UMEVCM6W

Links:

Dr. John Cush RheumNow ( View Tweet)
Top February Tweet: ACR Task Force published guidelines on RMD drug use w/ COVID vaccines. My views: 1. I agree, no change most DMARD, biologics 2. I disagree; I would NOT hold Orencia, I would NOT hold JAKi 3. I disagree: I would not hold MTX https://t.co/uSPfvJB8EC https://t.co/unOY1jvzTJ

Links:

Dr. John Cush RheumNow ( View Tweet)
Compared with no statin use; statin use in RA pts is assoc w/ 28% lower mortality risk. Population study of 19,614 RA pts w/ incident statin use, compared 1,883 statin users vs 1,883 nonusers. All-cause mortality was lower (HR 0.72;0.56-0.91) w/ statins https://t.co/onMlWoVdPL

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: Measureable Benefits to Treat-to-Target Management in RA https://t.co/iAvLWJGTXp https://t.co/NfNj3MWznI

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Live is a powerful, interactive meeting delivered by researchers, educators, & clinicians. The speaker list includes: Roy Fleischmann, Alan Matsumoto, Clay Cockerell, Eric Ruderman, Alexis Ogdie, Philip Robinson, Jeff Sparks, and more. https://t.co/vJlU0Z3Q3x https://t.co/fRbQbGRwoR

Links:

Dr. John Cush RheumNow ( View Tweet)
Pooled analysis of 16 observational RA registries (27 583 patients) shows that seropositivity was associated with better remission, LDAS and withdrawal rates for RTX and ABA, but not TNF inhibitors. https://t.co/aNphJpB7JB

Links:

Dr. John Cush RheumNow ( View Tweet)

QD Clinic: PFAPA Syndrome Recurrent Fevers, Stomatitis, Lymphadenopathy ? https://t.co/uMBk8e2wJO https://t.co/02ZMjRmOuU

Links:

Dr. John Cush RheumNow ( View Tweet)
Systemic Sclerosis is 5 times more prevalent in women than men. Analysis of epidemiology studies shows SSc prevalence as 17.6 per 100000 and pooled incidence of SSc was 1.4 per 100000 PYs. https://t.co/RyVIBUWyen

Links:

Dr. John Cush RheumNow ( View Tweet)

Its sill not SAFE! Avoid congregate settings! CDC report shows among 81 who participated in indoor high-intensity exercise classes - 68% developed COVID-19. 40% with COVID-19 attended class on day Sxs began. Most (76%) wore masks infrequently https://t.co/KLZauJUupN

Links:

Dr. John Cush RheumNow ( View Tweet)

In Israel (as of Feb 2021) 84% of those ≥70 years and 10% for <50 years have received 2 doses of the COVID Vaccine; as such the need for mechanical ventilation in the elderly has declined 67% with the implementation of COVID vaccines. https://t.co/9Qnv72QYUS

Links:

Dr. John Cush RheumNow ( View Tweet)

Listen to last weeks QD Clinics Podcasts (134-137 Feb 26) - RA or Not QD137 - RA or Not QD136 - Periorbital Mass QD135 - Periorbital Edema QD134 - PFAPA Syndrome https://t.co/pMXm6vFuBl

Links:

Dr. John Cush RheumNow ( View Tweet)

My Experience as a COVID19 Vaccine Trial Participant https://t.co/ILfXLUL8IZ

Links:

Dr. John Cush RheumNow ( View Tweet)

×